InsidersTradesSigma
Follow the AX1 share price and the full insider trade history of the company, a listed equity based in Australia. Shares trade on AU AU, under the authority of ASX. Operating in the Health Care sector, AX1 has logged 1 public disclosures. Market capitalisation: €447.9m. The latest transaction was disclosed on 21 May 2026 (Purchase). Among the most active insiders: Unknown. Every trade is free.
Analysts rate AX1 Buy (bullish), based on 12 analysts. Average price target: A$0.81.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.